| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 55.968 | 66.246 | 68.378 | 78.566 | 102.784 | 116.643 |
| Total Income - EUR | - | - | - | 0 | 57.209 | 66.247 | 68.379 | 78.567 | 102.785 | 116.656 |
| Total Expenses - EUR | - | - | - | 254 | 35.016 | 31.142 | 37.710 | 36.407 | 43.979 | 51.165 |
| Gross Profit/Loss - EUR | - | - | - | -254 | 22.194 | 35.105 | 30.669 | 42.160 | 58.806 | 65.491 |
| Net Profit/Loss - EUR | - | - | - | -254 | 21.634 | 34.680 | 29.985 | 41.390 | 57.778 | 61.991 |
| Employees | - | - | - | 0 | 3 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Tadormed Ao S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 15.731 | 15.157 | 14.870 | 14.540 | 14.585 | 14.541 | 16.208 |
| Current Assets | - | - | - | 9.514 | 17.895 | 28.972 | 25.585 | 29.913 | 53.171 | 73.947 |
| Inventories | - | - | - | 4.491 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 4.515 | 13.746 | 14.472 | 28.130 | 45.819 | 45.262 |
| Cash | - | - | - | 5.023 | 13.380 | 15.226 | 11.114 | 1.783 | 7.352 | 28.685 |
| Shareholders Funds | - | - | - | -211 | 21.427 | 34.730 | 30.430 | 41.439 | 57.827 | 62.040 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 25.456 | 11.625 | 9.112 | 9.815 | 3.120 | 10.037 | 28.352 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Tadormed Ao S.r.l.